Research

Understanding how to control the generation of regulatory T cells could have important implications for treating autoimmunity and cancer. Read More

A novel molecular “conversation” regulates kidney fibrosis – the final result of end-stage chronic kidney disease – suggesting new treatment options for this currently irreversible process. Read More

Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market. Read More

A Vanderbilt researcher says the EPA is being too expansive in how it measures carbon dioxide emissions. Read More

Simple heat treatments may give the frog immune system a boost and help it fight off a deadly fungal pathogen, according to a new study published July 10 in the journal Nature. Read More

It all started with a faint glow. It was November 1895, and the German physicist Wilhelm Roentgen was experimenting with an early cathode ray tube—a vacuum tube with a contained electric current. During his experiments he noticed an odd fluorescence in crystals on a nearby table. Surprisingly, the glow continued even… Read More

Asking lower-income people to contemplate buying coverage around the holiday season is a bad idea because they are too financially stressed, but a good time is tax refund season, says new research co-authored by John Graves, assistant professor of health policy. Read More

Vanderbilt researcher Bernard Rousseau, Ph.D., is being appointed to the Motor Function, Speech and Rehabilitation Study Section at the Center for Scientific Review, National Institutes of Health, for the term beginning July 1 and ending June 30, 2020. Read More

Muktar Aliyu, M.D., MPH, Dr.P.H., associate director for Research at the Vanderbilt Institute for Global Health, is the recipient of the 2014 Alumnus Award for Scientific Excellence from the University of Alabama at Birmingham School of Public Health. Read More

Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes. Read More

Vanderbilt University School of Medicine is fielding one of 10 teams of students selected to participate in a project aimed at identifying the most frequent users of health care. Read More

Christopher Serkin of Vanderbilt Law School has the "startling" opinion that government entities should be held legally responsible if they fail to make laws protecting the rights of property owners. Read More

A new study suggests that lowering the dose of radiation therapy for some head and neck cancer patients may improve outcomes and cause fewer long-term side effects. Read More

New Vanderbilt research suggests patients with advanced melanoma — the most deadly form of skin cancer — could safely benefit from a combination of immunotherapy and targeted therapies aimed at specific gene mutations. Read More

The factor ATF4 has a role in the toughness of bone and its resistance to fracture, suggesting new therapeutic targets. Read More

New views of how transporters move molecules across cell membranes are key to understanding how these proteins impact tumor cell drug resistance and inherited diseases such as cystic fibrosis. Read More

Two Vanderbilt engineers participated in the SmartAmerica Challenge EXPO in Washington D.C. Read More

In an observational study by researchers at Vanderbilt University Medical Center, adults with type 2 diabetes who take insulin in addition to the recommended first-line drug therapy, metformin, had a 30 percent higher risk of heart attack, stroke or death when compared to similar patients who instead augment their metformin regimen with a sulfonylurea. Read More

Students are being asked to bring a winning personal touch to sales at The Cosmetic Market as one challenge at the Vanderbilt Accelerator Summer Business Institute Read More

It's a puzzler that political scientists want to understand and strategists want to exploit: Asian Americans lean decidedly to the Democratic Party, despite many factors that indicate they should be a natural fit for the Republicans. Read More